JPS535112A - New cysteine derivatives - Google Patents

New cysteine derivatives

Info

Publication number
JPS535112A
JPS535112A JP2545576A JP2545576A JPS535112A JP S535112 A JPS535112 A JP S535112A JP 2545576 A JP2545576 A JP 2545576A JP 2545576 A JP2545576 A JP 2545576A JP S535112 A JPS535112 A JP S535112A
Authority
JP
Japan
Prior art keywords
cysteine derivatives
new cysteine
new
derivatives
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2545576A
Other languages
English (en)
Other versions
JPS565388B2 (ja
Inventor
Kouji Fujita
Masayuki Ooya
Hideo Koukai
Tadashi Iso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP2545576A priority Critical patent/JPS535112A/ja
Priority to GB7623/77A priority patent/GB1530071A/en
Priority to US05/771,743 priority patent/US4305958A/en
Priority to SE7702129A priority patent/SE439484B/xx
Priority to CH272677A priority patent/CH630069A5/de
Priority to CA273,318A priority patent/CA1079299A/en
Priority to DE2709820A priority patent/DE2709820C2/de
Priority to FR7706737A priority patent/FR2344533A1/fr
Publication of JPS535112A publication Critical patent/JPS535112A/ja
Priority to US05/880,348 priority patent/US4137420A/en
Publication of JPS565388B2 publication Critical patent/JPS565388B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2545576A 1976-03-08 1976-03-08 New cysteine derivatives Granted JPS535112A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2545576A JPS535112A (en) 1976-03-08 1976-03-08 New cysteine derivatives
GB7623/77A GB1530071A (en) 1976-03-08 1977-02-23 Cysteine derivatives
US05/771,743 US4305958A (en) 1976-03-08 1977-02-24 Cysteine derivatives
SE7702129A SE439484B (sv) 1976-03-08 1977-02-25 Forfarande for framstellning av n-(merkaptoacyl)cysteinderivat med slemlosande verkan
CH272677A CH630069A5 (de) 1976-03-08 1977-03-04 Verfahren zur herstellung von neuen cystein-derivaten.
CA273,318A CA1079299A (en) 1976-03-08 1977-03-07 Cysteine derivatives
DE2709820A DE2709820C2 (de) 1976-03-08 1977-03-07 N-(Mercaptoacyl)-L oder DL-cysteine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende mucolytische Mittel
FR7706737A FR2344533A1 (fr) 1976-03-08 1977-03-08 Nouveaux derives de la cysteine, procede pour leur preparation et application comme fluidifiant des expectorations
US05/880,348 US4137420A (en) 1976-03-08 1978-02-23 Cysteine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2545576A JPS535112A (en) 1976-03-08 1976-03-08 New cysteine derivatives

Publications (2)

Publication Number Publication Date
JPS535112A true JPS535112A (en) 1978-01-18
JPS565388B2 JPS565388B2 (ja) 1981-02-04

Family

ID=12166492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2545576A Granted JPS535112A (en) 1976-03-08 1976-03-08 New cysteine derivatives

Country Status (8)

Country Link
US (2) US4305958A (ja)
JP (1) JPS535112A (ja)
CA (1) CA1079299A (ja)
CH (1) CH630069A5 (ja)
DE (1) DE2709820C2 (ja)
FR (1) FR2344533A1 (ja)
GB (1) GB1530071A (ja)
SE (1) SE439484B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5622729A (en) * 1979-07-31 1981-03-03 Univ Rockefeller Mucin viscosity reducing agent
WO1982001000A1 (en) * 1980-09-20 1982-04-01 Iso T Disulfide type cysteine derivatives
JP2005298502A (ja) * 2004-04-06 2005-10-27 L'oreal Sa ケラチン線維の永久矯正へのジメルカプトアミドの使用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339600A (en) * 1976-05-10 1982-07-13 E. R. Squibb & Sons, Inc. Compounds for alleviating angiotensin related hypertension
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
JPS6058908B2 (ja) * 1978-10-11 1985-12-23 参天製薬株式会社 システイン誘導体
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
JPS57142962A (en) * 1981-02-28 1982-09-03 Santen Pharmaceut Co Ltd Cyclodextrin clathrate compound of sulfur-containing compound
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
FR2563218B1 (fr) * 1984-04-19 1986-06-20 Synthelabo Derives d'acide n-((chloro-2 phenyl)methylthio-3 oxo-1 propyl)-aminoacetique substitue en a, leur preparation et leur application en therapeutique
EP0161172A1 (fr) * 1984-04-19 1985-11-13 Synthelabo Dérivés d'acide n-(phenylmethylthio-3 oxo-1 propyl)-aminoacétique, leur préparation et leur application en thérapeutique
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
ES2012958A6 (es) * 1988-01-25 1990-04-16 Santen Pharmaceutical Co Ltd Procedimiento para preparar derivados de cisteina.
US5292926A (en) * 1988-01-25 1994-03-08 Santen Pharmaceutical Co., Ltd. Cysteine derivatives
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
JPH0449489U (ja) * 1990-08-31 1992-04-27
JP2814033B2 (ja) * 1992-01-10 1998-10-22 参天製薬株式会社 シスチン尿症治療剤
US6025393A (en) * 1995-09-25 2000-02-15 Santen Pharmaceutical Co., Ltd. Method for treatment of inflammatory intestinal diseases
US5670545A (en) * 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
AU2042200A (en) 1998-12-07 2000-06-26 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
CN1312149C (zh) * 2002-12-23 2007-04-25 史宝珠 合成Bucillamine的中间体 5，5－二甲基－2－硫酮－4－酮－1－硫－3－氧－杂戊环
US7875268B2 (en) * 2004-04-06 2011-01-25 L'oreal S.A. Dimercaptoamides, compositions comprising them as reducing agents, and processes for permanently reshaping keratin fibers therewith
CN101260101B (zh) * 2007-03-09 2010-05-26 上海信联化学制药有限公司 合成布溪那明的新中间体5,5-二甲基-1,3-酮-2,4-硫-杂戊环
CN103196729A (zh) * 2013-04-10 2013-07-10 吴鹏 用于处理粘液的试剂
WO2022153101A1 (en) 2021-01-12 2022-07-21 Optimus Drugs Private Limited Crystalline form i of bucillamine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2430455A (en) * 1944-11-20 1947-11-11 Parke Davis & Co Reaction products of s-benzyl penicillamines and g-penaldates and process for making same
US2900375A (en) * 1955-12-23 1959-08-18 Roussel Uclaf Method of making glutathione
CH451186A (de) * 1961-11-02 1968-05-15 Santen Phamarceutical Co Ltd Verfahren zur Herstellung von N-Mercaptopropionylglycin und dessen Derivaten
FR1491204A (fr) * 1962-08-10 1967-08-11 Santen Pharmaceutical Co Ltd Procédés pour la préparation des alpha-et beta mercaptopropionylglycocolle et de leurs dérivés
US3647834A (en) * 1969-08-11 1972-03-07 Mead Johnson & Co Zinc mercaptide n-acetylcysteine carboxylate salts
US3634365A (en) * 1969-08-27 1972-01-11 Dow Chemical Co Polymers of l-amino acid derivatives of s-(substituted benzyl) compounds
DE2132862A1 (de) * 1971-06-29 1973-01-18 Klosa Josef Dipl Chem Dr Rer N Mittel zur beseitigung von mundund koerpergeruechen
CA1009252A (en) * 1972-10-03 1977-04-26 Santen Pharmaceutical Co. N-(mercaptoacyl) aminoacids
DE2627069A1 (de) * 1975-06-19 1977-01-20 Ajinomoto Kk Verfahren zur herstellung von substituierten schwefelhaltigen l-aminosaeuren
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5622729A (en) * 1979-07-31 1981-03-03 Univ Rockefeller Mucin viscosity reducing agent
JPH0223526B2 (ja) * 1979-07-31 1990-05-24 Univ Rockefeller
WO1982001000A1 (en) * 1980-09-20 1982-04-01 Iso T Disulfide type cysteine derivatives
JP2005298502A (ja) * 2004-04-06 2005-10-27 L'oreal Sa ケラチン線維の永久矯正へのジメルカプトアミドの使用

Also Published As

Publication number Publication date
DE2709820C2 (de) 1982-07-29
US4305958A (en) 1981-12-15
SE7702129L (sv) 1977-09-09
DE2709820A1 (de) 1977-09-15
FR2344533A1 (fr) 1977-10-14
CH630069A5 (de) 1982-05-28
JPS565388B2 (ja) 1981-02-04
FR2344533B1 (ja) 1980-06-27
CA1079299A (en) 1980-06-10
SE439484B (sv) 1985-06-17
US4137420A (en) 1979-01-30
GB1530071A (en) 1978-10-25

Similar Documents

Publication Publication Date Title
JPS535112A (en) New cysteine derivatives
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
AU2222977A (en) Tetrahydro-echinocandin b derivatives
HK9585A (en) Nogarol derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1521873A (en) Cysteine derivatives
PT66360B (en) Nicotinoylaminotriazine derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
ZA773485B (en) Hydrazinopyridazine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
JPS532487A (en) Quinoxalinee1*44dioxide derivatives
GB1544289A (en) Thiazolinotriazine derivatives
JPS52105159A (en) Estrogene derivatives
AU2536577A (en) 2-nitroindandione derivatives
JPS5283495A (en) Thienothiazine derivatives
AU2680877A (en) Arylaminopyrimidine derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives